Indeed, exposure of CML cells containing both wild type BCR-ABL and BCR-ABL1 mutated T315I cells to an Smo inhibitor led to the purging of the mutated clone [14]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.